Greenwich LifeSciences Stock (NASDAQ: GLSI) stock price, news, charts, stock research, profile.
You can purchase shares of Greenwich LifeSciences (NASDAQ:GLSI) through any online brokerage.
Other companies in Greenwich LifeSciences’s space includes: Zura Bio (NASDAQ:ZURA), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Atossa Therapeutics (NASDAQ:ATOS) and Adaptimmune Therapeutics (NASDAQ:ADAP).
Greenwich LifeSciences has a consensus price target of $38.00.
The stock price for Greenwich LifeSciences (NASDAQ: GLSI) is $13.25 last updated November 21, 2024 at 4:16 PM EST.
There are no upcoming dividends for Greenwich LifeSciences.
Greenwich LifeSciences’s Q3 earnings are confirmed for Thursday, November 14, 2024.
There is no upcoming split for Greenwich LifeSciences.
Greenwich LifeSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.